Technology | April 29, 2015

Volpara Solutions Releases VolparaDensity 3.1

Latest version of breast density analytics software supports tomosynthesis data from all major vendors

VolparaDensity, 3.1, tomosynthesis, mammography

April 29, 2015 — Volpara Solutions announced the release of VolparaDensity version 3.1 at the Society of Breast Imaging’s SBI/ACR Breast Imaging Symposium in Orlando, Florida, April 25-28.

The latest version of VolparaDensity supports digital mammography from all leading vendors and tomosynthesis datasets from Hologic, GE and Siemens tomosynthesis systems. Additionally, VolparaDensity 3.1 supports Hologic sites that use C-View synthetic 2-D images and GE SenoClaire sites that acquire 2-D CC and 3-D MLO images. VolparaDensity uses the same algorithm to process both the acquired tomosynthesis projections and the raw data of a conventional 2-D mammogram. This reduces the challenges of visually determining breast density based on a review of tomosynthesis slices and the new synthetic 2-D images (C-View from Hologic, V-Preview from GE).

“We have been using VolparaDensity for more than two years and find it particularly helpful when assessing breast density in mammograms with a complex dispersion of fibroglandular tissue,” said Kathy Schilling, M.D., of the Christine Lynn Women's Health and Wellness Center at Boca Raton Regional Hospital in Boca Raton, Florida. “We are now very pleased to be using VolparaDensity together with our GE SenoClaire digital breast tomosynthesis acquisitions. Given the demands of reviewing the stacks of tomosynthesis slices and the new synthetic 2-D images, we appreciate the consistent density assessment we get from the Volpara software.”

VolparaDensity 3.1 supports additional features including new configuration flexibility for patient-specific compression pressure calculations and the ability to route patient results by Volpara’s U.S. Food and Drug Administration (FDA)-cleared Volpara Density Grades (VDG), which are analogous to the BI-RADS density categories. Based on a site’s imaging protocols for breast density and risk, users can configure the system to automatically send density results for women with very dense breasts to a specific interpreting radiologist or a breast density specialist at the site for review. This automatic routing may help improve the speed with which sites can identify women who would benefit from additional screening, particularly sites that perform same-day adjunctive screening.    

VolparaDensity is in use at breast imaging centers worldwide to help radiologists objectively assess density from both digital mammography and tomosynthesis images and to determine which women would benefit from additional screening. Highly correlated to breast magnetic resonance (MR) assessments, VolparaDensity automatically generates an objective measurement of volumetric breast density correlated to the American College of Radiology (ACR) breast density categories.

For more information: www.volparasolutions.com

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
Breast Cancer Places Greater Financial Burden on Black Women
News | Women's Health | May 16, 2018
Having breast cancer placed a significantly greater financial strain on black women than white women, according to a...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Overlay Init